Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of N-acetylcysteine efficacy for reducing craving in patients with methamphetamine dependency
IRCT201205317841N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in methamphetamine use disorder (MUD), sponsored by Isfahan University of Medical Sciences. Started Jun 2012; status: completed.
02
Drugs
acetylcysteine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT201205317841N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205317841N2.